AU1366701A - Antimicrobial and anti-inflammatory endovascular (cardiovascular) stent - Google Patents

Antimicrobial and anti-inflammatory endovascular (cardiovascular) stent

Info

Publication number
AU1366701A
AU1366701A AU13667/01A AU1366701A AU1366701A AU 1366701 A AU1366701 A AU 1366701A AU 13667/01 A AU13667/01 A AU 13667/01A AU 1366701 A AU1366701 A AU 1366701A AU 1366701 A AU1366701 A AU 1366701A
Authority
AU
Australia
Prior art keywords
endovascular
stent
antimicrobial
cardiovascular
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU13667/01A
Inventor
Clarence C. Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of AU1366701A publication Critical patent/AU1366701A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/404—Biocides, antimicrobial agents, antiseptic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/41—Anti-inflammatory agents, e.g. NSAIDs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/416—Anti-neoplastic or anti-proliferative or anti-restenosis or anti-angiogenic agents, e.g. paclitaxel, sirolimus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/45—Mixtures of two or more drugs, e.g. synergistic mixtures
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/60—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a special physical form
    • A61L2300/606—Coatings

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU13667/01A 1999-09-23 2000-09-22 Antimicrobial and anti-inflammatory endovascular (cardiovascular) stent Abandoned AU1366701A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40457799A 1999-09-23 1999-09-23
US09404577 1999-09-23
PCT/US2000/040979 WO2001021229A1 (en) 1999-09-23 2000-09-22 Antimicrobial and anti-inflammatory endovascular (cardiovascular) stent

Publications (1)

Publication Number Publication Date
AU1366701A true AU1366701A (en) 2001-04-24

Family

ID=23600177

Family Applications (1)

Application Number Title Priority Date Filing Date
AU13667/01A Abandoned AU1366701A (en) 1999-09-23 2000-09-22 Antimicrobial and anti-inflammatory endovascular (cardiovascular) stent

Country Status (2)

Country Link
AU (1) AU1366701A (en)
WO (1) WO2001021229A1 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10127011A1 (en) * 2001-06-05 2002-12-12 Jomed Gmbh Implant used for treating vascular narrowing or occlusion, especially for controlling restenosis contains FK506 in chemically bound or physically fixed form
WO2002065947A2 (en) 2001-02-16 2002-08-29 Abbott Laboratories Vascular Enterprises Limited Implants with fk506 for prophylaxis and treatment of restonoses
AU2002254158A1 (en) * 2001-03-08 2002-09-24 Volcano Therapeutics, Inc. Medical devices, compositions and methods for treating vulnerable plaque
FI20010898A0 (en) * 2001-04-30 2001-04-30 Ylae Herttuala Seppo Extracellular superoxide dismutase (EC-SOD) gene therapy to prevent restenosis
US8133501B2 (en) 2002-02-08 2012-03-13 Boston Scientific Scimed, Inc. Implantable or insertable medical devices for controlled drug delivery
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
US7993390B2 (en) 2002-02-08 2011-08-09 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
US6887270B2 (en) 2002-02-08 2005-05-03 Boston Scientific Scimed, Inc. Implantable or insertable medical device resistant to microbial growth and biofilm formation
EP1499344A1 (en) * 2002-04-30 2005-01-26 FIT Biotech Oyj Plc Medical device
US8920826B2 (en) 2002-07-31 2014-12-30 Boston Scientific Scimed, Inc. Medical imaging reference devices
US8192752B2 (en) * 2003-11-21 2012-06-05 Advanced Cardiovascular Systems, Inc. Coatings for implantable devices including biologically erodable polyesters and methods for fabricating the same
US7540997B2 (en) 2005-08-23 2009-06-02 Boston Scientific Scimed, Inc. Medical devices having alloy compositions
AU2007225040A1 (en) * 2006-03-15 2007-09-20 Promethean Lifesciences, Inc. Preparation and storage of stable, antimicrobially active materials
WO2008027720A2 (en) * 2006-08-28 2008-03-06 Wilson-Cook Medical Inc. Stent with antimicrobial drainage lumen surface
DE102008042578A1 (en) * 2008-10-02 2010-04-08 Biotronik Vi Patent Ag Implant with a body made of a biocorrodible manganese alloy
CN110343247B (en) * 2019-06-20 2022-01-04 西南民族大学 Polymer nano material for peroxidase mimic and preparation method thereof
CN110973143B (en) * 2019-09-18 2022-01-07 北京宇悦生物科技有限公司 Bactericide composition and application thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990013332A1 (en) * 1989-05-11 1990-11-15 Cedars-Sinai Medical Center Stent with sustained drug delivery
DE69110787T2 (en) * 1990-02-28 1996-04-04 Medtronic, Inc., Minneapolis, Minn. INTRALUMINAL PROSTHESIS WITH ACTIVE ELEMENTATION.
US5762638A (en) * 1991-02-27 1998-06-09 Shikani; Alain H. Anti-infective and anti-inflammatory releasing systems for medical devices
US5383928A (en) 1992-06-10 1995-01-24 Emory University Stent sheath for local drug delivery
US5869127A (en) * 1995-02-22 1999-02-09 Boston Scientific Corporation Method of providing a substrate with a bio-active/biocompatible coating

Also Published As

Publication number Publication date
WO2001021229A1 (en) 2001-03-29

Similar Documents

Publication Publication Date Title
AU4367400A (en) Radiopaque stents
AU2891899A (en) Intraluminal stent
AU4648500A (en) Intravascular stent system
AU2471599A (en) Endoluminal stents and their manufacture
AU3762100A (en) Multilayer stent
AU4690400A (en) Intravascular hinge stent
AU6000200A (en) Braided stent
AU7132900A (en) Tapered self-expanding stent
AU6583998A (en) Intravascular stent
AU6084398A (en) Expandable intravascular stent
AU4481500A (en) Variable strength stent
AU4975500A (en) Stent having antimicrobial agent
AU1897700A (en) Removable stent
AU3115897A (en) Intravascular stent
AU5384199A (en) Balloon expandable covered stents
AU1724099A (en) Vascular stent for reduction of restenosis
AU2001247654A1 (en) Radiopaque intraluminal stent
AU3121797A (en) Intraluminal stent
AU4497700A (en) Prosthetic grafts
AU3766499A (en) Braided stent
AU2002366571A1 (en) Combined balloon-expanding and self-expanding stent
AU5236699A (en) Improved stent configuration
AU8882998A (en) Multilayered metal stent
AU5738598A (en) Articulated expandable intraluminal stent
AU1366701A (en) Antimicrobial and anti-inflammatory endovascular (cardiovascular) stent

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase